Nucleic Acid Therapies At Harwell Campus This session will explore innovative strategies to enhance gene therapy for cystic fibrosis (cf). the focus will be on developing optimal gene constructs by utilizing shortened and optimized sequences, advanced codon usage, and other strategies to improve delivery, function, and expression. This session explores innovative strategies to enhance gene therapy for cystic fibrosis.
Nucleic Acid Therapeutics Successes Milestones And Upcoming Discipline groups, lunch and learns, plenaries, symposiums, and workshops from the cystic fibrosis foundation's 2025 north american cystic fibrosis conference. originally recorded. Opinions shared by these individuals belong solely to the nacfc panelists and speakers and do not represent those of the cystic fibrosis foundation unless explicitly stated. His work is supported by cf foundation grants and the cincinnati children's research foundation and he has extensive collaborations with groups across europe and usa. Location: 423 425 sw psych 2:30 pm 4:30 pm pdt s16 the promise of nucleic acid based therapies in cf: progress & prospects location: 420 422 ptac cftr 2:30 pm 4:30 pm pdt.
Looking Ahead What Does The Future Have In Store For Nucleic Acid His work is supported by cf foundation grants and the cincinnati children's research foundation and he has extensive collaborations with groups across europe and usa. Location: 423 425 sw psych 2:30 pm 4:30 pm pdt s16 the promise of nucleic acid based therapies in cf: progress & prospects location: 420 422 ptac cftr 2:30 pm 4:30 pm pdt. Abstracts of the 2025 north american cystic fibrosis conference 22 25 october 2025 • seattle, washington • publication of this abstract supplement is supported by the cystic fibrosis foundation. Dr. polineni studies genetic modifiers of lung disease severity in people with cf to identify novel treatment targets. Nacfc offers three plenary sessions. below, you’ll find details for the 2025 sessions, along with links to view recordings and downloadable slides in the downloads section. This taken into account, new approaches to cf management are being developed, including the ones using gene therapy methods to deliver nucleic acids to the affected cells to address the primary (genetic) cause of the pathology and, through that, mitigate the course of the disease.
Full Schedule Abstracts of the 2025 north american cystic fibrosis conference 22 25 october 2025 • seattle, washington • publication of this abstract supplement is supported by the cystic fibrosis foundation. Dr. polineni studies genetic modifiers of lung disease severity in people with cf to identify novel treatment targets. Nacfc offers three plenary sessions. below, you’ll find details for the 2025 sessions, along with links to view recordings and downloadable slides in the downloads section. This taken into account, new approaches to cf management are being developed, including the ones using gene therapy methods to deliver nucleic acids to the affected cells to address the primary (genetic) cause of the pathology and, through that, mitigate the course of the disease.
Comments are closed.